HY-50 17 mg/ml 3 ml
Is the registration number of your country not listed? Then this product falls within the cascade control system. For more information, click here (please check the rules of your country, they may deviate).
En stock
HY-50 17 mg/ml 3 ml
Composition
Sodium hyaluronate 17 mg/ml. Pre-loaded 3 ml single-dose glass syringes.
Indications
For intra-articular and intravenous treatment of lameness caused by joint dysfunction associated with non-infectious synovitis. Do not use in cases of joint infection.
Adverse reactions
Transient mild swelling and/or heat has been reported in treated joints (2.7%). These self-limiting local signs resolve spontaneously within48 hours, and do not negate a successful therapeutic outcome.
Indicaciones de uso
Dosage and administration route
Intravenous use: 3 ml intravenously repeatedat weekly intervals for a total of three treatments.
For single intra-articular injection: 3 ml (51 mg) intra-articularly into medium sized and large joints. Smaller joints such as intertarsal, tarsometatarsal and interphalangeal joints can be treated with a 1.5 ml dose (25.5 mg). More than one joint may be treated at the same time.
Excess synovial fluid should be removed whenever possible prior to injection. Remove product from refrigerator approximately 10 minutes before performing injection.
The injection should be administered under strict aseptic conditions. Ensure removal of dirt, hair, topical medicaments and soap/antiseptic residues.
Intra-articular injections should not be made through overlying skin that is infected, blistered, scurfed or otherwise compromised. A sterile dressing and clean bandage should be applied after injection, as appropriate for the particular joint treated.
Single dose syringes made ready for injection shall be used immediately. Any unused portion of a syringeis to be discarded.
